These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25796513)

  • 1. The role of fibroblast growth factor 21 in diabetes and its complications: A review from clinical perspective.
    Liu JJ; Foo JP; Liu S; Lim SC
    Diabetes Res Clin Pract; 2015 Jun; 108(3):382-9. PubMed ID: 25796513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum fibroblast growth factor 21 was elevated in subjects with type 2 diabetes mellitus and was associated with the presence of carotid artery plaques.
    An SY; Lee MS; Yi SA; Ha ES; Han SJ; Kim HJ; Kim DJ; Lee KW
    Diabetes Res Clin Pract; 2012 May; 96(2):196-203. PubMed ID: 22293928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of fibroblast growth factor 21 with baseline and new on-study microvascular disease in the Fenofibrate Intervention and Event Lowering in Diabetes study.
    Ong KL; Januszewski AS; O'Connell R; Buizen L; Jenkins AJ; Xu A; Sullivan DR; Barter PJ; Scott RS; Taskinen MR; Rye KA; Keech AC;
    Diabetologia; 2015 Sep; 58(9):2035-44. PubMed ID: 26055067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21.
    Iglesias P; Selgas R; Romero S; Díez JJ
    Eur J Endocrinol; 2012 Sep; 167(3):301-9. PubMed ID: 22740503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful Glycemic Control Decreases the Elevated Serum FGF21 Level without Affecting Normal Serum GDF15 Levels in a Patient with Mitochondrial Diabetes.
    Murakami T; Ueba Y; Shinoto Y; Koga Y; Kaneda D; Hatoko T; Kato T; Yonemitsu S; Muro S; Oki S
    Tohoku J Exp Med; 2016 Jun; 239(2):89-94. PubMed ID: 27212224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic change of serum FGF21 levels in response to glucose challenge in human.
    Lin Z; Gong Q; Wu C; Yu J; Lu T; Pan X; Lin S; Li X
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1224-8. PubMed ID: 22539584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin-induced inhibition of the mitochondrial respiratory chain increases FGF21 expression via ATF4 activation.
    Kim KH; Jeong YT; Kim SH; Jung HS; Park KS; Lee HY; Lee MS
    Biochem Biophys Res Commun; 2013 Oct; 440(1):76-81. PubMed ID: 24041694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct changes in serum fibroblast growth factor 21 levels in different subtypes of diabetes.
    Xiao Y; Xu A; Law LS; Chen C; Li H; Li X; Yang L; Liu S; Zhou Z; Lam KS
    J Clin Endocrinol Metab; 2012 Jan; 97(1):E54-8. PubMed ID: 22013098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of FGF21 on glycemic control.
    Strowski MZ
    Horm Mol Biol Clin Investig; 2017 Jun; 30(2):. PubMed ID: 28593912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor 21 in cardio-metabolic disorders: a systematic review and meta-analysis.
    Lakhani I; Gong M; Wong WT; Bazoukis G; Lampropoulos K; Wong SH; Wu WKK; Wong MCS; Ong KL; Liu T; Tse G;
    Metabolism; 2018 Jun; 83():11-17. PubMed ID: 29410351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of FGF21 in type 1 diabetes and its complications.
    Zhang J; Weng W; Wang K; Lu X; Cai L; Sun J
    Int J Biol Sci; 2018; 14(9):1000-1011. PubMed ID: 29989062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes.
    Xiao Y; Liu L; Xu A; Zhou P; Long Z; Tu Y; Chen X; Tang W; Huang G; Zhou Z
    Cardiovasc Diabetol; 2015 Jun; 14():72. PubMed ID: 26047614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum fibroblast growth factor-21 levels are associated with carotid atherosclerosis independent of established cardiovascular risk factors.
    Chow WS; Xu A; Woo YC; Tso AW; Cheung SC; Fong CH; Tse HF; Chau MT; Cheung BM; Lam KS
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2454-9. PubMed ID: 23887638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating fibroblast growth factor 21 levels predict progressive kidney disease in subjects with type 2 diabetes and normoalbuminuria.
    Lee CH; Hui EY; Woo YC; Yeung CY; Chow WS; Yuen MM; Fong CH; Xu A; Lam KS
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1368-75. PubMed ID: 25625802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating FGF21 Levels in Human Health and Metabolic Disease.
    Keuper M; Häring HU; Staiger H
    Exp Clin Endocrinol Diabetes; 2020 Nov; 128(11):752-770. PubMed ID: 31108554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exenatide treatment decreases fasting fibroblast growth factor 21 levels in patients with newly diagnosed type 2 diabetes mellitus.
    Hu Y; Liu J; Zhang H; Xu Y; Hong T; Wang G
    Diabetes Metab; 2016 Nov; 42(5):358-363. PubMed ID: 27178737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity.
    Mraz M; Bartlova M; Lacinova Z; Michalsky D; Kasalicky M; Haluzikova D; Matoulek M; Dostalova I; Humenanska V; Haluzik M
    Clin Endocrinol (Oxf); 2009 Sep; 71(3):369-75. PubMed ID: 19702724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The U-shaped relationship between fibroblast growth factor 21 and microvascular complication in type 2 diabetes mellitus.
    Jung CH; Jung SH; Kim BY; Kim CH; Kang SK; Mok JO
    J Diabetes Complications; 2017 Jan; 31(1):134-140. PubMed ID: 27839924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High plasma level of fibroblast growth factor 21 is an Independent predictor of type 2 diabetes: a 5.4-year population-based prospective study in Chinese subjects.
    Chen C; Cheung BM; Tso AW; Wang Y; Law LS; Ong KL; Wat NM; Xu A; Lam KS
    Diabetes Care; 2011 Sep; 34(9):2113-5. PubMed ID: 21750278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study.
    Ong KL; Januszewski AS; O'Connell R; Jenkins AJ; Xu A; Sullivan DR; Barter PJ; Hung WT; Scott RS; Taskinen MR; Keech AC; Rye KA
    Diabetologia; 2015 Mar; 58(3):464-73. PubMed ID: 25425220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.